Chronic high fat diet impairs glucagon like peptide-1 sensitivity in vagal afferents

The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway

Caroline R. Abbott, Mariana P. Monteiro, Caroline J. Small et al. · Brain Research · 2005 · 594 citations

Life Sciences, Neuroscience, Physiology +13

Glucagon-Like Peptide-1-(7–36)Amide Is Transformed to Glucagon-Like Peptide-1-(9–36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine¹

Lene Hansen, Carolyn F. Deacon, Cathrine Ørskov et al. · Endocrinology · 1999 · 582 citations · Full text

Life Sciences, Biochemistry, Endocrinology +15

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

Neşe I ̇meryüz, Ayhan Bozkurt, Tamer Coşkun et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1997 · 427 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4

Scott E. Kanoski, Samantha M. Fortin, Myrtha Arnold et al. · Endocrinology · 2011 · 346 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin

T. H. Moran, A. R. Baldessarini, Cynthia F. Salorio et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1997 · 227 citations

Life Sciences, Neuroscience, Physiology +17